NCT04823494

Brief Summary

This document describes a clinical validation study for a double-blind repeated-measures comparative study of the Great Nordic (GN) self-fitting method to a validated audiology-best-practices method when fitting the GN Self-fitting Hearing Aid, a device intended for persons aged 18-75 years old who have mild-to-moderate hearing loss. A crossover wear-time field trial will be conducted. The focus of the study is on the validity of the self-fitting process used to select appropriate frequency-gain characteristics for the GN Self-fitting Hearing Aid, and the safety and effectiveness of the device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 30, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

June 18, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2021

Completed
5 months until next milestone

Results Posted

Study results publicly available

May 11, 2022

Completed
Last Updated

May 11, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

March 26, 2021

Results QC Date

February 2, 2022

Last Update Submit

April 18, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Aided Abbreviated Profile of Hearing Aid Benefit (APHAB)

    The APHAB is a 24-item self-assessment of the amount of trouble the respondent has with communication in everyday situations. Sample question: "When I'm at the dinner table with several people, and I am trying to have a conversation with one person, understanding speech is difficult." For each of the 24 items, person asked to select one of the following percentages to indicate how frequently this occurs: Always (99%); Almost Always (87%); Generally (75%); Half-the-time (50%); Occasionally (25%); Seldom (12%); or Never (1%). Mean scale scores are expressed as a percentage or proportion representing the average frequency of difficulty experienced. An APHAB global score based on the 18 items from the three speech-communication subscales was used in the statistical analyses. APHAB scores were obtained unaided (Visit 1) and following use of the hearing aids for 10-14 days for each fit (Visits 2 \& 3; aided). The primary outcome is the mean difference in aided scores, Self-Fit minus Pro-Fit.

    10-14 days

Secondary Outcomes (1)

  • Quick Speech in Noise Test (QuickSIN)

    Measurement after 10-14-day wear time for each fit.

Study Arms (2)

Pro-Fit followed by Self Fit

EXPERIMENTAL

Hearing aids fit by a professional hearing care provider using best practices followed by patient ...

Device: Hearing aids

Self-Fit followed by ProFit

EXPERIMENTAL

Hearing aids fit by patient followed by ...

Device: Hearing aids

Interventions

Earbud style hearing aids fit to both ears

Pro-Fit followed by Self FitSelf-Fit followed by ProFit

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mild-to-moderate bilateral sensorineural hearing loss (thresholds from 250 - 8000 Hz less than 60 decibels Hearing Level (dB HL) and from 2000 - 8000 Hz, at least one threshold greater than 20 dB HL)
  • Mix of male and female subjects (aiming for a representative balance)
  • Mix of prior hearing-aid use (aiming for 70-80% persons with no prior hearing aid use)
  • years old (aiming for primarily 50-70 years old, with avg. age \~65 years)
  • Apple iPhone (iOS 14 compatible or greater, as required for the SELF-FIT app)
  • Able to read and comprehend English
  • Patient willing to provide informed consent

You may not qualify if:

  • Hearing outside of limits noted above
  • Self-reported ear-related pathology (including chronic severe dizziness or chronic severe tinnitus)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sertoma Speech and Hearing Center

Palos Hills, Illinois, 60465, United States

Location

Vanderbilt University

Nashville, Tennessee, 37235, United States

Location

Related Publications (2)

  • Cox RM, Alexander GC. The abbreviated profile of hearing aid benefit. Ear Hear. 1995 Apr;16(2):176-86. doi: 10.1097/00003446-199504000-00005.

    PMID: 7789669BACKGROUND
  • Killion MC, Niquette PA, Gudmundsen GI, Revit LJ, Banerjee S. Development of a quick speech-in-noise test for measuring signal-to-noise ratio loss in normal-hearing and hearing-impaired listeners. J Acoust Soc Am. 2004 Oct;116(4 Pt 1):2395-405. doi: 10.1121/1.1784440.

    PMID: 15532670BACKGROUND

MeSH Terms

Conditions

Hearing Loss, Sensorineural

Interventions

Hearing Aids

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and SuppliesSensory Aids

Limitations and Caveats

The minimum N needed to achieve the desired statistical power was 32 and 40 participants were enrolled to allow for attrition. In the end, only 3 participants were exited from the study or withdrew, leaving 37 with complete data. Of the 3 with incomplete data, 2 resulted from technical issues with the devices or app. However, both per-protocol analyses (summarized above) and intention-to-treat analyses yielded the same findings, indicating that the few missing data were inconsequential.

Results Point of Contact

Title
Todd Fortune
Organization
GN

Study Officials

  • Todd Ricketts, Ph.D.

    Vanderbilt University

    PRINCIPAL INVESTIGATOR
  • Sumitrajit Dhar, Ph.D.

    Northwestern University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2021

First Posted

March 30, 2021

Study Start

June 18, 2021

Primary Completion

September 30, 2021

Study Completion

December 20, 2021

Last Updated

May 11, 2022

Results First Posted

May 11, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations